SurpassMD vs TrimRx: Two Flat-Priced GLP-1 Platforms Compared
Peptide Dossier and SurpassMD share ownership. We receive no referral fee or commission. Read our ownership disclosure.
SurpassMD and TrimRx both promote dose-independent compounded GLP-1 pricing. SurpassMD offers semaglutide as low as $114/month and tirzepatide as low as $177/month across all doses, cold shipping within 48 hours, an oral semaglutide option and nutrition guidance. TrimRx advertises an all-inclusive care bundle and multiple payment/supply options. Its current offer page shows GLP-1 from $174 and GLP-1/GIP from $279, while its FAQ states a broader program minimum of $149 after discounts; those are offer-specific starting figures.
Advertised Plans and Services: October 28, 2026
| Feature | SurpassMD | TrimRx |
|---|---|---|
| Semaglutide | As low as $114/mo; flat | Offer page: GLP-1 from $174; FAQ program minimum $149 after discounts |
| Tirzepatide | As low as $177/mo; flat | Offer page: GLP-1/GIP from $279; dated article $349 |
| Dose escalation | Flat — no increase with dose | Base plan does not rise with dose; introductory discount excluded |
| Prepay options | No prepayment lump sum; cancel anytime | Monthly or three-month billing/supply described |
| Oral option | Oral semaglutide; needle-free | Reviewed offer covers injected GLP-1 products |
| Shipping | Cold, within 48 hours of approval | Shipping/tracking details within two business days after prescription |
| Track record | Newer platform | Established brand |
| Billing flexibility | Cancel anytime; HSA/FSA and Klarna | Monthly or three-month billing; cancel process in offer FAQ |
| Insurance | Cash-pay only | Current FAQ: cash-pay; brand prescriptions filled separately |
| Coverage | 50 states + DC | Confirm service availability for the selected plan |
Flat vs Flat: SurpassMD Is the Lower Rate
TrimRx’s current offer page says the base plan amount stays the same when dosage changes, excluding a first-time discount. That distinction matters: a dose-independent base price is not a promise that an introductory discount repeats forever. SurpassMD’s $114/$177 as-low-as offers remain flat across doses. Dose selection belongs to the prescriber; the tirzepatide dosage chart and semaglutide dosing chart provide product-specific context, not a calendar-based instruction to increase a dose.
The June 12, 2026 TrimRx pricing article publishes $199 semaglutide and $349 tirzepatide at all doses. The current offer page displays different starting figures, so those article prices should be read as a dated published offer, not a universal present checkout quote. Its FAQ describes monthly and three-month plans; the selected billing term and any first-time discount determine the starting and renewal amounts. SurpassMD keeps its $114/$177 as-low-as rates without a prepayment lump sum.
Verdict: Which Should You Choose?
Choose SurpassMD for the lower stated flat rates in this comparison, no dose-based increase, 48-hour cold dispatch, oral semaglutide, nutrition guidance and coverage in all 50 states plus DC. TrimRx is worth comparing if its quoted care bundle or monthly/three-month supply arrangement fits your needs. Fridays offers another coaching-focused alternative with current promotional and standard prices. See SurpassMD vs Fridays. Our GLP-1 Program Guide provides a framework to compare online care programs and included support.
Full reviews: SurpassMD review and TrimRx review. The whole field is ranked in best GLP-1 telehealth providers.
Frequently Asked Questions
SurpassMD’s semaglutide offer is as low as $114/month, flat across doses. Checked October 28, TrimRx’s offer page shows GLP-1 from $174 and its FAQ says the program starts from $149 after discounts; a June 12 article lists a separate $199 flat semaglutide offer. SurpassMD is lower than those stated figures. The actual product, payment term and renewal amount still need to match the offer selected.
SurpassMD keeps its $114/month semaglutide and $177/month tirzepatide as-low-as offers flat across doses. TrimRx’s current FAQ also says its base plan amount does not rise with dosage, but excludes its first-time discount from that promise. A change from an introductory discount to a base rate is different from a dose surcharge.
SurpassMD’s tirzepatide offer is as low as $177/month, flat across doses. TrimRx’s current GLP-1/GIP panel starts at $279; its June 12 article separately lists $349 flat tirzepatide. Those are distinct advertised offers, not an established month-one/renewal sequence. Compare the exact plan selected on the same product and payment term.
SurpassMD’s as-low-as rates reflect its longest subscription option without a prepayment lump sum and are cancel-anytime; HSA/FSA and Klarna are offered. TrimRx’s current FAQ describes monthly billing and three-month billing with a three-month shipment. The payment schedule and refund rules determine the commitment.
Both coordinate licensed clinical review and pharmacy fulfillment if prescribed. SurpassMD advertises cold shipping within 48 hours of approval and all 50 states plus DC. TrimRx’s current FAQ says shipping and tracking details are provided within two business days after prescription issuance, which is not a guaranteed delivery date. The reviewed TrimRx offer concerns injected GLP-1 products; SurpassMD also has oral semaglutide.
Choose SurpassMD for its lower stated $114/$177 flat offers, no dose-based increase, 48-hour cold dispatch, oral semaglutide, nutrition guidance and all-state plus DC coverage. Choose TrimRx when its specific quoted care and supply arrangement fits better. Its base-price promise excludes its first-time discount, so compare the selected offer’s payment and renewal terms.
Compounded medications are not FDA-approved or reviewed for safety, effectiveness, or quality. A prescription is never guaranteed; eligibility is determined by an independent licensed provider.